1. Home
  2. UA vs AMRX Comparison

UA vs AMRX Comparison

Compare UA & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UA
  • AMRX
  • Stock Information
  • Founded
  • UA 1996
  • AMRX 2002
  • Country
  • UA United States
  • AMRX United States
  • Employees
  • UA N/A
  • AMRX N/A
  • Industry
  • UA Apparel
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UA Consumer Discretionary
  • AMRX Health Care
  • Exchange
  • UA Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • UA 2.8B
  • AMRX 2.9B
  • IPO Year
  • UA N/A
  • AMRX N/A
  • Fundamental
  • Price
  • UA $4.90
  • AMRX $9.56
  • Analyst Decision
  • UA
  • AMRX Strong Buy
  • Analyst Count
  • UA 0
  • AMRX 4
  • Target Price
  • UA N/A
  • AMRX $11.50
  • AVG Volume (30 Days)
  • UA 7.4M
  • AMRX 1.6M
  • Earning Date
  • UA 08-08-2025
  • AMRX 08-05-2025
  • Dividend Yield
  • UA N/A
  • AMRX N/A
  • EPS Growth
  • UA N/A
  • AMRX N/A
  • EPS
  • UA 0.23
  • AMRX 0.01
  • Revenue
  • UA $5,114,713,000.00
  • AMRX $2,852,914,000.00
  • Revenue This Year
  • UA N/A
  • AMRX $9.56
  • Revenue Next Year
  • UA $2.69
  • AMRX $6.27
  • P/E Ratio
  • UA $20.98
  • AMRX $875.66
  • Revenue Growth
  • UA N/A
  • AMRX 9.81
  • 52 Week Low
  • UA $4.62
  • AMRX $6.69
  • 52 Week High
  • UA $10.62
  • AMRX $9.79
  • Technical
  • Relative Strength Index (RSI)
  • UA 32.93
  • AMRX 68.42
  • Support Level
  • UA $4.90
  • AMRX $9.20
  • Resistance Level
  • UA $5.13
  • AMRX $9.79
  • Average True Range (ATR)
  • UA 0.18
  • AMRX 0.25
  • MACD
  • UA 0.02
  • AMRX 0.01
  • Stochastic Oscillator
  • UA 31.69
  • AMRX 76.29

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: